Joseph Newman

1.9k total citations
35 papers, 684 citations indexed

About

Joseph Newman is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Agronomy and Crop Science. According to data from OpenAlex, Joseph Newman has authored 35 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Agronomy and Crop Science. Recurrent topics in Joseph Newman's work include Viral Infections and Immunology Research (11 papers), Animal Disease Management and Epidemiology (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Joseph Newman is often cited by papers focused on Viral Infections and Immunology Research (11 papers), Animal Disease Management and Epidemiology (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Joseph Newman collaborates with scholars based in United Kingdom, United States and Denmark. Joseph Newman's co-authors include F. Brown, Walden K. Roberts, Tobias J. Tuthill, G. N. Woode, Roland R. Rueckert, J. C. Bridger, Amin S. Asfor, Dalan Bailey, Nazia Thakur and Dawid Swieboda and has published in prestigious journals such as Nature, The Lancet and Nature Communications.

In The Last Decade

Joseph Newman

32 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Newman United Kingdom 15 289 225 133 101 87 35 684
Roberto Mateo United States 14 340 1.2× 285 1.3× 177 1.3× 144 1.4× 66 0.8× 24 920
Barbara Small United States 8 494 1.7× 101 0.4× 261 2.0× 247 2.4× 86 1.0× 9 821
Wenjun Liu China 15 163 0.6× 250 1.1× 74 0.6× 116 1.1× 65 0.7× 40 624
Tomokazu Tamura Japan 14 160 0.6× 311 1.4× 149 1.1× 252 2.5× 132 1.5× 44 712
M F Ypma-Wong United States 10 297 1.0× 319 1.4× 502 3.8× 69 0.7× 16 0.2× 12 731
Mason Lai United States 9 263 0.9× 145 0.6× 37 0.3× 31 0.3× 34 0.4× 24 578
R. G. Marusyk Canada 15 214 0.7× 154 0.7× 57 0.4× 50 0.5× 27 0.3× 38 695
Silvia A. González Argentina 20 229 0.8× 497 2.2× 148 1.1× 52 0.5× 59 0.7× 54 1.1k
Fernando Valiente‐Echeverría Chile 24 710 2.5× 447 2.0× 176 1.3× 22 0.2× 49 0.6× 54 1.3k
Stephanie L. Moon United States 17 751 2.6× 418 1.9× 126 0.9× 48 0.5× 19 0.2× 25 1.4k

Countries citing papers authored by Joseph Newman

Since Specialization
Citations

This map shows the geographic impact of Joseph Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Newman more than expected).

Fields of papers citing papers by Joseph Newman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Newman. The network helps show where Joseph Newman may publish in the future.

Co-authorship network of co-authors of Joseph Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Newman. A scholar is included among the top collaborators of Joseph Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Newman. Joseph Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lean, Fabian Z. X., Giulia Gallo, Joseph Newman, et al.. (2025). Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivores. Journal of General Virology. 106(4).
2.
Scott, Sam, Nicola S. Logan, Joseph Newman, et al.. (2025). Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024. EBioMedicine. 116. 105760–105760. 1 indexed citations
3.
4.
Wing, Peter A. C., Nathalie Schmidt, Hao Wang, et al.. (2023). An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity. PLoS Pathogens. 19(5). e1011323–e1011323. 8 indexed citations
5.
Foster, William S., Joseph Newman, Nazia Thakur, et al.. (2023). ChAdOx1 nCoV‐19 vaccination generates spike‐specific CD8+ T cells in aged mice. Immunology and Cell Biology. 101(6). 479–488.
6.
Newman, Joseph, Nazia Thakur, Thomas P. Peacock, et al.. (2022). Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2. Nature Microbiology. 7(8). 1180–1188. 42 indexed citations
7.
Kelly, James T., et al.. (2022). Membrane Interactions and Uncoating of Aichi Virus, a Picornavirus That Lacks a VP4. Journal of Virology. 96(7). e0008222–e0008222. 4 indexed citations
8.
Doremalen, Neeltje van, Jonathan E. Schulz, Danielle R. Adney, et al.. (2022). ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants. Nature Communications. 13(1). 4610–4610. 17 indexed citations
9.
Newman, Joseph, David J. Rowlands, & Tobias J. Tuthill. (2021). An Engineered Maturation Cleavage Provides a Recombinant Mimic of Foot-and-Mouth Disease Virus Capsid Assembly-Disassembly. Life. 11(6). 500–500. 7 indexed citations
10.
Mousnier, Aurélie, Andrew Bell, Dawid Swieboda, et al.. (2018). Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nature Chemistry. 10(6). 599–606. 90 indexed citations
11.
Kotecha, Abhay, Jingshan Ren, Amin S. Asfor, et al.. (2018). Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays. PLoS ONE. 13(8). e0201853–e0201853. 3 indexed citations
12.
13.
Newman, Joseph. (1998). Radiologic technology's role in sports medicine.. PubMed. 69(6). 535–50; quiz 551. 1 indexed citations
14.
Martin, M., John Barr Dewar, & Joseph Newman. (1988). Polymerized serum albumin beads possessing slow release properties for use in vaccines. Vaccine. 6(1). 33–38. 14 indexed citations
15.
Newman, Joseph. (1987). CHAPTER 2: Background Forces in Policies for Care and Treatment of Disability. Marriage & Family Review. 11(1-2). 25–44. 3 indexed citations
16.
Newman, Joseph. (1980). Certification/licensure: premature priorities?. PubMed. 40(11-12). 336–9. 1 indexed citations
17.
Newman, Joseph. (1976). Faculty Attitudes Toward Handicapped Students.. 4 indexed citations
18.
Newman, Joseph & F. Brown. (1976). Absence of Poly (A) from the Infective RNA of Nodamura Virus. Journal of General Virology. 30(1). 137–140. 39 indexed citations
19.
Brown, F. & Joseph Newman. (1963). In vitromeasurement of the potency of inactivated foot-and-mouth disease virus vaccines. Journal of Hygiene. 61(3). 345–351. 30 indexed citations
20.
Newman, Joseph & George J. Wischner. (1960). The performance of an hospitalized neuropsychiatric sample on the edwards personal preference schedule. Journal of Clinical Psychology. 16(1). 99–100. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Mateo Breakdown of academic impact, for papers by Barbara Small Breakdown of academic impact, for papers by Wenjun Liu Breakdown of academic impact, for papers by Tomokazu Tamura Breakdown of academic impact, for papers by M F Ypma-Wong Breakdown of academic impact, for papers by Mason Lai Breakdown of academic impact, for papers by R. G. Marusyk Breakdown of academic impact, for papers by Silvia A. González Breakdown of academic impact, for papers by Fernando Valiente‐Echeverría Breakdown of academic impact, for papers by Stephanie L. Moon
Rankless by CCL
2026